Other languages MacroGenics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 26/06/2024 am IST			5-day change	1st Jan Change
4.29 ^USD	-4.67%		+4.13%	-55.41%

24/06	MacroGenics, Inc.(NasdaqGS:MGNX) dropped from S&P Biotechnology Select Industry Index	CI
13/06	Transcript : MacroGenics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-13-2024 10:00 AM

Sector Update: Health Care Stocks Higher Late Afternoon	11/05
Sector Update: Health Care	11/05
Top Midday Decliners	11/05
Sector Update: Health Care Stocks Edge Higher Premarket Friday	10/05
Top Premarket Decliners	10/05
MacroGenics Says Five Patients Died in Cancer Study	10/05
MacroGenics Q1 Loss Widens, Revenue Falls	10/05
MacroGenics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Sector Update: Health Care Stocks Mixed in Afternoon Trading	04/04
MacroGenics Shares Surge Following Phase 2 Update on Prostate Cancer Drug	04/04
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Renewed Rate Cut Hopes	04/04
Sector Update: Health Care	04/04
MacroGenics Says Cancer Drug Study Update Set for May After Conference Miss	04/04
MacroGenics, Inc. Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures	04/04
MacroGenics Narrows 2023 Net Loss, Revenue Drops; Shares Fall After-Hours	08/03
MacroGenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Macrogenics Insider Sold Shares Worth $813,501, According to a Recent SEC Filing	07/03
Macrogenics Insider Sold Shares Worth $615,000, According to a Recent SEC Filing	07/03
Macrogenics Insider Sold Shares Worth $1,258,142, According to a Recent SEC Filing	08/02
Sector Update: Health Care Stocks Retreat Late Afternoon	21/12

No results for this search